Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

124 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

NCT06800313

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Rocky Mountain Cancer Center Colorado Springs, Colorado, United States
  • Sarah Cannon Research Institute 1 Denver, Colorado, United States
View all 18 locations
View Trial Details
Recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

NCT05997615

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
Locations
  • Investigational Site Number: 403 Palo Alto, California, United States
  • Investigational Site Number: 401 Houston, Texas, United States
  • Investigational Site number: 404 Fairfax, Virginia, United States
  • Investigational Site Number: 400 Seattle, Washington, United States
View Trial Details
Recruiting

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

NCT07649681

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +42 more
Locations
  • Universitätsklinikum Augsburg Augsburg, Bavaria, Germany
  • Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
  • LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center München, Bavaria, Germany
  • Klinikum der Technischen Universität München (TUM Klinikum) München, Bavaria, Germany
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +91 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • The University of Kansas Cancer Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details

Related conditions